To restrict the availability of prohibited drugs, MoH will soon constitute special task force

  • News
  • October 3, 2017

To stop the misuse of the Restricted and prohibited drugs like oxytocin which are freely available in the open market stores, High Court, Himachal Pradesh, sent strict notice to all State Drug Controllers in the country to take regulatory control over manufacture, sale, and distribution of oxytocin.

Dr. G N Singh, the Drug Controller General of India (DCGI) mentioned that they received a letter from health and family ministry welfare vide F.No BD/VET/CELL/13.2014(Pt-l) dated 09-05-2017 enlisting the measures to keep regulatory control on prohibited drugs like Oxytocin.

In a letter, the court clearly mentioned constituting a special force to keep a check on distribution, manufacturing, and sale in each district of each State to confirm no prohibited/regulated drug can be easily available in the market.

States with their concerned departments where licenses for  oxytocin manufacturing have been issued should examine the licenses of all existing manufacturers to confirm that the same has been issued strictly in accordance with Drugs and Cosmetics Act, 1940 and Rules 1945 and that the manufactures mandatorily comply with all the conditions of Drugs and Cosmetics Act, 1940 and Rules 1945, framed thereunder.  In case of violations, Immediate appropriate actions as per the statutory provisions should have been taken.

The court also mentioned that the State Drug Controllers will place details of licenses issued to various manufacturers along with a monthly statement of production and sales of oxytocin with complete particulars and details made by the manufacturers on their websites by every 10th of the each month. Oxytocin manufacturers submit needs to submit data prior so that data can be accessible at Drug Controller by 7th of every month.

These steps if followed accordingly then we can expect good output from it. The manufacturers of all prohibited drugs need to maintain records, as required under the law and the same shall be produced for inspection after every quarter before the officer specifically deployed for this purpose by the DCGI.

  • Related Posts

    13 Years after Oxytocin Order, HC Seeks Compilance Status

    GWALIOR: The Gwalior Bench of the Madhya Pradesh High Court has directed the state government to submit a comprehensive compliance status report. This order addresses the implementation of the court’s…

    Centre Pushes Haryana to Fast-Track AIIMS Rewari

    New Delhi | August 18, 2025 — The Union government has urged Haryana to speed up work on AIIMS Rewari (Majra) and resolve on-ground hurdles so the institute can open…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Nearly Three in Ten Products in Indian Local Markets Perceived as Counterfeit; Pharmaceuticals and FMCG among Worst-Affected Sectors: ASPA–CRISIL Intelligence Report

    Nearly Three in Ten Products in Indian Local Markets Perceived as Counterfeit; Pharmaceuticals and FMCG among Worst-Affected Sectors: ASPA–CRISIL Intelligence Report

    Culture reports reveal bacteria damaged cornea of five patients from Kuchaman

    Culture reports reveal bacteria damaged cornea of five patients from Kuchaman

    FSSAI prohibits Dabur from selling food products with ‘100%’ claims

    FSSAI prohibits Dabur from selling food products with ‘100%’ claims

    ORSL reinforces its commitment to improve diarrhoeal prevention in children

    ORSL reinforces its commitment to improve diarrhoeal prevention in children

    ‘Donors got mixer grinders, cash’: blood banks in Bengal under scanner over ‘illegal’ sale to other States

    ‘Donors got mixer grinders, cash’: blood banks in Bengal under scanner over ‘illegal’ sale to other States

    CREATE Medicines expands targeted in vivo CAR platform through strategic research collaboration and exclusive license pact with Monash University

    CREATE Medicines expands targeted in vivo CAR platform through strategic research collaboration and exclusive license pact with Monash University